At Stanford Medicine, Catalyst accelerates bold innovations with funding, incubation support, network connections, and more to drive real-world, global impact. Swift Bio joined Catalyst in May 2024 as one such venture. Photo caption: SWIFT Bio’s leaders John Gorzynski, DVM, PhD, and Sneha Goenka, PhD, with Euan Ashley, MD, PhD at the Ashley Lab. Led by Chief Scientific Officer, John Gorzynski, DVM, PhD (Stanford ’21) and Chief Executive Officer, Alex Johnson, Swift Bio is an

Catalyst Innovator Dr. Helen Bronte-Stewart, a Stanford Medicine professor of neurology, has dedicated her career to understanding how the brain controls movement and what happens when that process breaks down. As the global lead investigator of an international clinical trial, she spearheaded the development of an adaptive deep brain stimulation (aDBS) device — essentially a pacemaker for the brain — that senses brain activity in real time and tailors electrical pulses accor

Five years is not a long time in health care innovations. It takes, on average, 10 to 15 years to bring a new drug to market and three to seven years for new medical devices. And that’s if you have the funding and know what you’re doing. More often than not, medical innovations tumble into the ”valley of death” between bench and bedside, never crossing from initial scientific discovery to commercial product and patient care. Five years ago, Susan Hiniker , MD, an associate pr

Learn how Stanford Medicine Catalyst is helping TrNK launch a clinic-ready therapy for solid tumors, whose stubborn defenses often thwart effective treatment. If you have an innovation that could be a good fit for Catalyst, consider applying by March 16. At Stanford Medicine, Catalyst accelerates innovations with funding, incubation support, network connections and more to drive real-world, global impact. TrNK joined Catalyst in May 2024 as one such venture. When the laborato

Kidney Pod, a Stanford Medicine Catalyst supported project, is a novel organ transplantation device which maintains organs at an optimal temperature throughout the transplantation procedure.

A project supported by Stanford Medicine Catalyst is revolutionizing patient care through pharmacogenomics — personalized prescriptions...